This analysis demonstrated that our findings are consistent with the 2016 Endocrine Society recommended approach to primary aldosteronism which specify that patients with plasma renin activity below detection levels combined with an aldosterone concentration > 20 ng/dl and spontaneous hypokalemia can bypass confirmatory testing. The gene discussed is REN; the disease is Hypokalemia.